Loading...

PODCAST

Let"s Combinate - Drugs + Devices with Subhi Saadeh

Hello Combi-Nation! Our industry fee complicated sometimes. Drugs, devices, clinical trials, submissions, sterilization validation, design control, risk management, market access reimbursement, the list goes on. My name is Subhi Saadeh. I"ve spent over a decade in medical device, pharma, and combination product development. My goal is mastery, so this podcast is to ask questions I have to people who may have the answers. Whether you"re background is Pharma, Device or both, I invite you to

science life sciences

All Episodes

00:12:57

257 - 21 CFR Part 4 Explained: CGMP Requirements for...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/10/05

21 CFR Part 4 sets the CGMP requirements for combination products. If your product has a drug and a device in it, you're on the hook for both sets of regulations. In this video, I walk through Part 4 Subpart A section by section: the scope, the key definitions, which CGMPs apply, and the two ways to comply, including the streamlined approach under 4.4(b).Updated for February 2026, when the device side moved to the QMSR and ISO 13485, plus the new medical gas provisions.Working on your first

en

00:09:29

256 - The New FDA Inspection Playbook: Where to Start...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/09/28

QMSR became effective on February 2, 2026. Alongside that change, FDA retired the Quality System Inspection Technique (QSIT) and began using the inspection process described in Compliance Program 7382.850.What does that mean for industry and how should we use the new program to prepare?In this episode of Let’s Combinate: Drugs + Devices, Subhi Saadeh introduces a four-part series on QMSR inspection readiness. We compare QSIT’s four major inspection subsystems with the new program’s six QMS areas,

en

00:11:30

255 - Audit Interview Techniques: How Good Auditors...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/09/21

A huge part of the job is knowing how to interview people, understand how work is actually performed, and corroborate what you hear against records, observations, and other objective evidence.In this episode, I pulled one of the lessons from the auditing course Andy Robertson and I developed and walk through some of the fundamentals of audit interviewing: building rapport, asking open-ended questions, avoiding overly checklist-driven interviews, corroborating information, managing group interviews

en

00:12:25

254 - Saying No Is the Easy Part of Quality

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/09/13

Quality has a reputation for saying no.Sometimes that’s exactly the right call. Other times, “no” is just the easiest answer.In this episode, Subhi breaks down four situations where Quality should absolutely stop the train, and a few where it’s worth stepping back and asking what’s really driving the no in the first place.Subhi covers:when there is real patient or product riskwhen the evidence doesn’t support the decisionwhen moving forward would clearly violate requirements or SOPswhen schedule or

en

00:45:53

253 - FDA Is Making Big Changes to Its Inspection...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/09/07

FDA is changing how it organizes and deploys its investigators but it isn’t simply returning to the old generalist model.Eric Pittman spent more than 20 years at FDA, conducted approximately 800+ inspections, led the Bioresearch Monitoring Division West, and served for a decade as editor-in-chief of FDA’s Investigations Operations Manual.In this episode, Eric explains how FDA investigators are trained to think, the difference between technical expertise and inspection skill, why investigators

en

00:13:06

252 - Acceptance Sampling Fundamentals: AQL,...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/08/31

Acceptance sampling is one of the most commonly used and commonly misunderstood tools in quality.In this video, I break down the fundamentals of acceptance sampling: what it is, what an AQL actually means, the difference between sampling by attributes and variables, and the risk involved when we use a sample to make an accept/reject decision about an entire lot.We’ll also introduce Operating Characteristic (OC) curves, producer risk, and consumer risk — because acceptance sampling is

en

00:49:29

251 - The Future of Drug Delivery: Orals,...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/08/24

In this episode, Subhi Saadeh sits down with Steven Kaufman, Founder of Combination Product Solutions, Inc. and fractional Chief Commercial Officer at Portal Instruments, to discuss where the drug delivery device market is headed and what it takes for new technologies to actually make it to patients.Steven brings more than 21 years of experience across drug delivery and combination products, spanning strategy, business development, commercialization, consulting, and executive leadership.The

en

00:02:47

I'm Changing The Podcast

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/08/18

After 250 straight weeks of publishing Let’s Combinate every Wednesday, I’m making a change.Starting now, new episodes will go live Mondays at 5:00 AM CT.To everyone who watches, listens, shares, or has been part of the journey: thank you. This podcast has been one of the most enriching things I’ve ever done.See you Monday.🌐 https://letscombinate.com📅 https://calendly.com/letscombinate/let-s-combinate-intro-session💼 https://www.linkedin.com/in/subhi-saadeh-1169aa21About Subhi SaadehSubhi Saadeh

en

00:11:15

250 - PIC/S PI 006-4 (2026): What Changed in...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/08/12

PIC/S has issued its first major update to its qualification and validation recommendations in nearly 20 years. PI 006-4 replaces PI 006-3 from 2007 and brings the document much closer to how qualification and validation are approached today.In this video, I walk through where PI 006-4 fits within the broader GMP framework, how it relates to EU Annex 15, and the sections I think are most worth paying attention to.A few of the major themes include a much stronger emphasis on quality risk management

en

00:14:29

249 - The Best Audit Advice Nobody Told Me

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/08/05

Audits are not supposed to be gotchas, and they are not meant to evaluate one person’s work in isolation. A good audit looks at whether a system is suitable, effective, and adequate and where it may need to improve.In this video, I share the lessons I learned as I moved from being audited and supporting audit rooms to conducting audits as a certified lead auditor:1) Audit the system, not the person: The goal is to understand how the system operates, not to catch an individual making a mistake.2)

en

00:08:54

248 - What Is a Quality Unit? QA vs. QC Explained

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/07/29

What is a Quality Unit and how do Quality Assurance and Quality Control fit within it?In this episode, I explain the practical differences between the Quality Unit, QA, and QC across pharmaceutical, medical-device, and combination-product companies. We’ll look at the Quality Unit’s major responsibilities, why QA is generally system- and process-focused, why QC is generally testing- and product-focused, and why the organizational structure varies between companies.CHAPTERS00:00 What is a Quality

en

00:08:17

247 - Why Everyone in Pharma and MedTech Should Work...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/07/22

Quality is often treated like a necessary function rather than an exciting career path. But working in quality can give professionals in pharma, biotech, and MedTech a much broader understanding of how regulated businesses actually operate.In this video, Subhi Saadeh explains three reasons everyone in the industry should consider spending time in quality:You learn how the business works. Quality follows the product across its lifecycle from development and suppliers through manufacturing,

en

00:08:56

246 - The 3 Ways to Structure a Quality Management...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/07/15

Most discussions about One QMS focus on harmonization.But before deciding whether a single global Quality Management System is the right approach, it's worth understanding the three primary ways organizations structure a QMS.In this episode, I compare centralized, decentralized, and federated (hybrid) Quality Management System models, including the trade-offs of each in terms of ownership, standardization, flexibility, governance, and decision-making.We also walk through how the document

en

00:45:12

245 - Reducing a 14-Step Emergency Injection to a...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/07/08

In this episode of Let’s Combinate: Drugs + Devices, Subhi Saadeh talks with Julia Anthony, founder and chief strategy officer of Solution Medical, about adrenal crisis, emergency hydrocortisone, and what it takes to build a drug-device combination product from a patient need.Julia was born with salt-wasting congenital adrenal hyperplasia, a life-threatening form of adrenal insufficiency. Because her body cannot make cortisol, she takes cortisol replacement daily and may need an emergency

en

00:08:49

244 - 5 Critical Quality Differences Between Drugs...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/07/01

Download the free Drug vs. Device Quality comparison guide here: https://letscombinate.kit.com/216fbfc6c2In this Let’s Combinate episode, Subhi explains why drug and device quality are not the same and highlights five key areas where they differ for combination products.Drug quality often focuses on consistently remaking the product that was proven clinically, using critical quality attributes, specifications, analytical methods, stability, process validation, and batch release.Device quality

en

00:14:38

243 - Why Kitting A Finished Medical Device with a...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/06/24

Chat with Subhi: https://calendly.com/letscombinate/let-s-combinate-intro-sessionFinished medical devices can create a lot of surprises when they are added to combination product kits.A needle, vial adapter, filter, or transfer device may already be sterile, cleared, qualified, and sold at massive scale.But already on the market does not automatically mean ready for your combination product.In this episode, I talk through the challenges of selecting finished medical devices for combination product

en

00:12:10

242 - Pharma/MedTech Audits: 6 Strategies for...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/06/17

One of the hardest parts of auditing is not knowing what to look for.It is deciding where to start. Do you trace a deviation? Walk the process? Focus on one department? Audit CAPA across the organization? Or pull on a thread that does not quite make sense?In this video, Subhi walks through six audit strategies from the ASQ Certified Quality Auditor Body of Knowledge and explains how they apply in real-world pharma, biotech, and combination product audits.The six strategies covered are:1. Tracing2

en

00:10:29

241 - ICH Q14 Explained: Have We Been Validating...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/06/10

In this final episode of the ICH Quality series, we walk through the most important concepts in ICH Q14 and how they fit into the broader ICH quality framework.Rather than reviewing the guideline section by section, this episode focuses on the ideas that are most useful in practice: Why does ICH Q14 start with the Analytical Target Profile (ATP)? How is it different from ICH Q2? How do you develop analytical procedures using a science- and risk-based approach? And what does all of this have to do

en

00:11:08

240 - ICH Q13: Continuous Manufacturing, Batches,...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/06/03

ICH Q13 explains how pharmaceutical companies can apply batch definition, traceability, control strategy, validation, release, and lifecycle management to continuous manufacturing of drug substances and drug products.Learn more:https://www.letscombinate.comSchedule a call:https://calendly.com/letscombinate/let-s-combinate-intro-sessionIn this episode, Subhi Saadeh explains ICH Q13 and the key concepts behind continuous manufacturing in pharmaceutical manufacturing.The core question behind ICH Q13 is

en

00:10:45

239 - ICH Q12: What’s Binding? Established Conditions...

Let"s Combinate - Drugs + Devices with Subhi Saadeh ·

2026/05/27

In this episode, Subhi breaks down ICH Q12, the guideline focused on post-approval change management and pharmaceutical product lifecycle management.The core question behind ICH Q12 is simple: once a product is approved, what is actually binding, what is supporting information, and how should future changes be managed?This episode covers the major Q12 concepts, including reporting categories, Established Conditions, supporting information, Post-Approval Change Management Protocols, the Product

en

137 results

Similar Podcasts

Beyond the Divide

Koala Moon

The SCP Experience

Dr. NoSleep Studios

John Michael Godier"s Event Horizon

John Michael Godier

La Science CQFD

France Culture

A Moment of Science

Indiana Public Media